Coronary Artery Disease Clinical Trial
— SUPREME IIOfficial title:
Pressure Microcatheter for Physiological Measurements - A Prospective, Multicenter, Randomized Study
Verified date | December 2023 |
Source | Insight Lifetech Co., Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
TruePhysio pressure microcatheter is a novel device for evaluating the functional significance of coronary stenosis, and its safety and efficacy on the measurement of hyperemic index have been validated in the previous SUPREME study (NCT03541577). This study will further evaluate the safety and efficacy of the physiological indices measured by the TruePhysio pressure microcatheter, including resting and hyperemic indices, with respect to the physiological indices measured by the Pressure Wire.
Status | Completed |
Enrollment | 487 |
Est. completion date | December 1, 2022 |
Est. primary completion date | July 16, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - At least 18 years old; - Having at least one 30-90% coronary artery stenosis by visual estimation under angiogram; - Clinically indicated to physiological assessment. Exclusion Criteria: - Unable to comprehend, or unwilling to sign the informed consent form; - Contraindicated to the procedures of invasive coronary angiography or percutaneous coronary intervention; - Clinically diagnosed with severe coronary artery vasospasm; - Other operator-discerned facts that will make enrollment or the procedure impossible to complete. |
Country | Name | City | State |
---|---|---|---|
China | Peking University Third Hospital | Beijing | Beijing |
China | First Affiliated Hospital of Chongqing Medical University | Chongqing | Chongqing |
China | Guangdong Provincial People's Hospital | Guangzhou | Guangdong |
China | Sir Run Run Shaw Hospital | Hangzhou | Zhejiang |
China | First Affiliated Hospital of Harbin Medical University | Harbin | Heilongjiang |
China | Shandong Provincial Hospital | Jinan | Shandong |
China | Shanghai Zhongshan Hospital | Shanghai | Shanghai |
China | First Affiliated Hospital of Xinjiang Medical University | Ürümqi | Xinjiang |
China | First Affiliated Hospital of Wenzhou Medical University | Wenzhou | Zhejiang |
China | Xiamen Cardiovascular Hospital, Xiamen University | Xiamen | Fujian |
China | Affiliated Hospital of Zunyi Medical University | Zunyi | Guizhou |
Lead Sponsor | Collaborator |
---|---|
Insight Lifetech Co., Ltd. | First Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Xinjiang Medical University, Guangdong Provincial People's Hospital, Peking University Third Hospital, Shandong Provincial Hospital, Shanghai Zhongshan Hospital, Sir Run Run Shaw Hospital, Xiamen Cardiovascular Hospital, Xiamen University, Zunyi Medical College |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The accuracy of cRR measured by TruePhysio pressure microcatheter in diagnosing myocardial ischemia | Using FFR measured by TruePhysio pressure microcatheter as the reference. The optimal binary cutoff for cRR is determined by using Youden's index. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The area under the Receiver Operating Characteristic (ROC) curve (AUC) of cRR measured by the TruePhysio pressure microcatheter in diagnosing myocardial ischemia | Using FFR measured by TruePhysio pressure microcatheter as the reference | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The sensitivity, specificity, positive and negative predictive values of cRR measured by TruePhysio pressure microcatheter in diagnosing myocardial ischemia | Using FFR measured by TruePhysio pressure microcatheter as the reference. The optimal binary cutoff for cRR is determined by using Youden's index. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The AUC of cRR measured by the TruePhysio pressure microcatheter in diagnosing myocardial ischemia | Using FFR measured by Pressure Wire as the reference | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The overall accuracy, sensitivity, specificity, positive and negative predictive values of cRR in diagnosing myocardial ischemia | Using FFR measured by Pressure Wire as the reference. The optimal binary cutoff for cRR is determined by using Youden's index. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The AUC of RFR measured by the Pressure Wire in diagnosing myocardial ischemia | Using FFR measured by Pressure Wire as the reference | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The overall accuracy, sensitivity, specificity, positive predictive value and negative predictive value of RFR in diagnosing myocardial ischemia | Using FFR measured by Pressure Wire as the reference. The binary cutoff for RFR is determined by previous study as 0.89. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The overall accuracy, sensitivity, specificity, positive and negative predictive values of the hybrid cRR-FFR scheme, concluded by TruePhysio pressure microcatheter, in diagnosing myocardial ischemia | Using FFR measured by the TruePhysio pressure microcatheter as the reference. The gray zone is defined as where the false positive and negative ratios are equal. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The proportion of the subcohort, whose cRR value is in the gray zone of the hybrid cRR-FFR scheme, to the entire cohort | Using FFR measured by the TruePhysio pressure microcatheter as the reference. Each enrolled patient only has one vessel to be physiologically assessed. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | When the cRR value is out of the gray zone of the hybrid cRR-FFR scheme, the cRR-FFR hybrid scheme's accuracy in diagnosing myocardial ischemia | Using FFR measured by the TruePhysio pressure microcatheter as the reference | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The overall accuracy, sensitivity, specificity, positive and negative predictive values of the hybrid RFR-FFR scheme, concluded by Pressure Wire, in diagnosing myocardial ischemia | Using FFR measured by the Pressure Wire as the reference. The gray zone is determined by previous study as [0.86, 0.93]. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | The proportion of the subcohort, whose RFR value is in the gray zone of the hybrid RFR-FFR scheme, to the entire cohort | Using FFR measured by the Pressure Wire as the reference. Each enrolled patient only has one vessel to be physiologically assessed. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | When the RFR value is out of the gray zone of the hybrid RFR-FFR scheme, the RFR-FFR hybrid scheme's accuracy in diagnosing myocardial ischemia | Using FFR measured by the Pressure Wire as the reference | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Pearson correlation between the cRR and FFR measured by TruePhysio pressure microcatheter | Paired values are analyzed by Pearson correlation | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Passing-Bablok regression analysis between the cRR and FFR measured by TruePhysio pressure microcatheter | Paired values are analyzed by Passing-Bablok regression | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Pearson correlation between the RFR and FFR measured by Pressure Wire | Paired values are analyzed by Pearson correlation | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Passing-Bablok regression analysis between RFR and FFR measured by Pressure Wire | Paired values are analyzed by Passing-Bablok regression | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Passing-Bablok regression analysis between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire | Paired cRR-RFR values by the two systems are analyzed in Passing-Bablok regression | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Bland-Altman analysis between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire | Paired cRR-RFR values by the two systems are analyzed in Bland-Altman analysis | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Pearson's correlation between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire | Paired cRR-RFR values by the two systems are analyzed in Pearson correlation | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Pearson correlation between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire | Paired FFR values by the two systems are analyzed by Pearson correlation | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Passing-Bablok regression analysis between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire | Paired FFR values by the two systems are analyzed by Passing-Bablok regression | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Mean bias between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire as assessed by Bland-Altman analysis | Using FFR measured by Pressure Wire as the reference | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Results of Bland-Altman analysis between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire among the patients with atrial fibrillation or in severe stenosis or with small vessels | Using FFR measured by Pressure Wire as the reference. The severe stenosis is defined as the diameter stenosis higher than 70%, while the small vessel is defined as the reference vessel diameter smaller than 2.5 mm. | Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Rate of significant drift | Drift is defined as the difference between FFR value and 1 when pressure sensor is pulled back to coronary artery ostium for verification.
Significant drift occurs when the device has a drift with absolute value > 0.03; alternatively, drift is regarded as significant when the Pd/Pa at the ostium for verification is either <0.97 or >1.03. Significant drift is recorded per appearance, regardless whether the measurement is eventually successful or not. Its rate is calculated as: Times of significant drift occurred in total / Times of measuring attempted in total |
Immediate upon completion of the procedure for the last enrolled patient | |
Secondary | Rate of device success | Device success is defined when a device successfully crossed the lesion and completed acquisition of valid physiological values.
For any vessel, if valid cRR and FFR values by the TruePhysio pressure microcatheter are acquired, the measurement of TruePhysio pressure microcatheter is successful in the specific vessel, disregarding how many times it was attempted; For any vessel, if valid RFR and FFR values by the Pressure Wire are acquired, the measurement of Pressure Wire is successful in the specific vessel, disregarding how many times it was attempted. Rate of device success is calculated as: Vessels with device success / Total vessels |
Immediate upon completion of the procedure for the last enrolled patient |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |